Intensive glucose therapy and clinical implications of recent data: A consensus statement from the Global Task Force on Glycaemic Control

International Journal of Clinical Practice

Volumn 63, Issue 10, 2009, Pages 1421-1425

  Akalin, S ^a   Berntorp, K ^b   Ceriello, A ^c   Das, A K ^d   Kilpatrick, E S ^e   Koblik, T ^f   Munichoodappa, C S ^g   Pan, C Y ^h   Rosenthall, W ⁱ   Shestakova, M ^j   Wolnik, B ^k   Woo, V ^l   Yang, W Y ^m   Yilmaz, M T ⁿ  

^a MARMARA UNIVERSITY   (Turkey)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^e HULL ROYAL INFIRMARY   (United Kingdom)

^f JAGIELLONIAN UNIVERSITY   (Poland)

^g Bangalore Hospital   (India)

^h CHINESE PLA GENERAL HOSPITAL   (China)

ⁱ Trillium Health Centre   (Canada)

^j ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^k MEDICAL UNIVERSITY OF GDANSK   (Poland)

^l UNIVERSITY OF MANITOBA   (Canada)

^m CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

ⁿ ISTANBUL UNIVERSITY   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; VASCULAR DISEASE; WEIGHT GAIN; CONSENSUS DEVELOPMENT; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HYPERGLYCEMIA; METABOLISM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS;

EID: 70349237376     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02165.x     Document Type: Conference Paper

References (12)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
3. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005 353 : 2643 2653.
4. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 359 : 1577 1589.
5. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 358 : 2545 2559.
6. Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 358 : 2560 2572.
7. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009 360 : 129 139.
8. Chalmers J, Cooper ME. UKPDS and the legacy effect. N Engl J Med 2008 359 : 1618 1620.
9. Holman RR, Paul SK, Bethel MA et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008 359 : 1565 1576.
10. Juutilainen A, Lehto S, Ronnemaa T et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 2008 31 : 714 719.
11. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003 348 : 383 393. (Pubitemid 36159355)
12. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008 358 : 580 591.